Skip to main content

Dr. Ellen Snyder Provides Clinical Perspectives to “Everyday Health” Regarding Patients’ Use of Psoriatic Arthritis (PsA) Drugs

April 6, 2021
In her recent interview, Dr. Snyder stresses that it's particularly important for patients to take PsA drugs exactly as prescribed, in order to achieve optimal therapeutic outcomes.

Dr. Amanda Nelson Was Recently Interviewed by USA Today, In Advance of FDA Advisory Committee Review of Tanezumab

April 5, 2021
Dr. Nelson provided expert opinion regarding the drug, which was being evaluated as a potential new treatment for arthritis pain.

Drs. Onyi Iweala and Sofija Volertas Interviewed by ABC-11 & CBS-17 (Respectively), Regarding How to Differentiate COVID-19 Symptoms from Allergies

March 30, 2021
The allergists provided useful information on both conditions, and discussed what to do if someone suspects they are experiencing symptoms.

Dr. Lara Longobardi Receives NC-TraCS Grant to Explore Use of Macrophages as Carriers for Drug Delivery in Preventing and Treating Osteoarthritis

March 4, 2021
The specially modified nanoparticles have the capability of delivering therapeutic drugs to inflammation sites.

Ralph Alberto, an Undergraduate Student in Dr. Richard Loeser’s Lab, Is Selected as the Irvine Hagadorn Award Recipient

February 25, 2021
The award is presented to the top junior biology major based on academic & research excellence, and contributions to the Biology Department.

Dr. Richard Loeser Co-Authors JAMA Paper Evaluating High-Intensity Strength Training for Osteoarthritis Knee Pain

February 17, 2021
The new research findings show that high intensity training was not more beneficial than lower intensity training or a healthy education control intervention.

Dr. Yvonne Golightly Named Associate Editor of Osteoarthritis and Cartilage

February 11, 2021
Dr. Golightly is an internationally recognized osteoarthritis researcher and epidemiologist.

Dr. Richard Loeser Co-Authors Comprehensive JAMA Review Article, Providing Key Insights Into the Causes, Diagnosis & Treatment of Hip and Knee Osteoarthritis

February 10, 2021
The article provides a review of previous, current and evolving views regarding the disease, including treatments ranging from behavior modification, to advanced new therapies.

UNC’s New Immuno-Oncology Prospective Database and Registry is Now Open for Patient Enrollment

February 8, 2021
Dr. Rumey Ishizawar founded the multi-disciplinary UNC Immuno-Oncology Group (IOG) in 2017 to optimize clinical management of cancer patients who develop immune related adverse events (irAEs).

The TARC Core Center for Clinical Research (CCCR) Announces RFA for Pilot & Feasibility Studies

February 4, 2021
The objective of the pilot and feasibility program is to provide seed money of up to $25K for 1 year to initiate new and innovative projects in the areas of phenotyping and precision medicine that will enhance work being done in the CCCR.